CutisPharma, Inc.

CutisPharma, Inc.

CutisPharma, Inc.

Overview
Date Founded

1998

Headquarters

841 Woburn Street,Wilmington, MA 01887

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Medical Support Services
Hospitals & Patient Services

Company Description

CutisPharma, Inc. develops and distributes pharmaceutical products and technologies. The firms offers bulk drug products that present alternatives for the preparation of compounded prescriptions by offering unit of use prescription compounding kits which benefits all key stakeholders, including physicians, pharmacists, and patients. The company was founded by Indu A. Muni in 1998 and is headquartered in Wilmington, MA.

Contact Data
Trying to get in touch with decision makers at CutisPharma, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President, Chief Executive Officer & Director

Chief Financial Officer

General Counsel

Chief Commercial Officer

Vice President

Associate

Quality Control Inspector

Board of Directors

Former Group President at Cardinal Health, Inc.

Chief Executive Officer at Azurity Pharmaceuticals

Paths to CutisPharma, Inc.
Potential Connections via
Relationship Science
You
CutisPharma, Inc.
Recent Transactions
Details Hidden

NovaQuest Capital Management LLC purchases CutisPharma, Inc. from Ampersand Management LLC

Transaction Advisors
Legal Advisor

Advised onNovaQuest Capital Management LLC purchases CutisPharma, Inc. from Ampersand Management LLC

Investment Advisor

Advised onNovaQuest Capital Management LLC purchases CutisPharma, Inc. from Ampersand Management LLC

Co-Chair, Healthcare Practice

Advised onNovaQuest Capital Management LLC purchases CutisPharma, Inc. from Ampersand Management LLC

Legal Advisor

Advised onNovaQuest Capital Management LLC purchases CutisPharma, Inc. from Ampersand Management LLC

Associate

Advised onNovaQuest Capital Management LLC purchases CutisPharma, Inc. from Ampersand Management LLC

Investors
Details Hidden

NovaQuest seeks investment opportunities in middle market companies located in the US with enterprise value of up to $500 million and revenue ranging from $20 - $100 million. The firm targets companies operating in the fields of pharmaceutical, medical technology, life sciences industry,,clinical/outsourcing, provider services, facility services and healthcare IT. The firm provides financing for growth stage capital requirements.

Details Hidden

Ampersand Management LLC invests in middle market companies located in North America and Europe. The firm focuses on companies with revenues between $10 and $100 million. They targets companies operating in the fields of healthcare technology, healthcare services, pharma services and laboratory services. They provides financing for growth, MBO, corporate divestitures and recapitalization capital requirements with an investment size ranging between $10 and $50 million. They acquires both majority and minority interests.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by CutisPharma, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of CutisPharma, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and CutisPharma, Inc..